Core Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Core Laboratories has a total shareholder equity of $237.4M and total debt of $160.4M, which brings its debt-to-equity ratio to 67.5%. Its total assets and total liabilities are $588.0M and $350.5M respectively. Core Laboratories's EBIT is $58.9M making its interest coverage ratio 4.4. It has cash and short-term investments of $14.9M.
Key information
67.5%
Debt to equity ratio
US$160.37m
Debt
| Interest coverage ratio | 4.4x |
| Cash | US$14.91m |
| Equity | US$237.42m |
| Total liabilities | US$350.53m |
| Total assets | US$587.95m |
Recent financial health updates
No updates
Recent updates
Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?
Mar 26
Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price
Mar 02Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts
Nov 09Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture
Sep 08Core Laboratories: 'Spooked The Herd' In June, Things Might Be Looking Up
Aug 16Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors
Jul 05The Returns On Capital At Core Laboratories (NYSE:CLB) Don't Inspire Confidence
May 25Financial Position Analysis
Short Term Liabilities: CLB's short term assets ($229.0M) exceed its short term liabilities ($85.5M).
Long Term Liabilities: CLB's short term assets ($229.0M) do not cover its long term liabilities ($265.1M).
Debt to Equity History and Analysis
Debt Level: CLB's net debt to equity ratio (61.3%) is considered high.
Reducing Debt: CLB's debt to equity ratio has reduced from 157.6% to 67.5% over the past 5 years.
Debt Coverage: CLB's debt is well covered by operating cash flow (20.9%).
Interest Coverage: CLB's interest payments on its debt are well covered by EBIT (4.4x coverage).